Edition:
United Kingdom

Cellectar Biosciences Inc (CLRB.OQ)

CLRB.OQ on NASDAQ Stock Exchange Capital Market

2.69USD
19 Oct 2018
Change (% chg)

-- (--)
Prev Close
$2.69
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
53,459
52-wk High
$17.30
52-wk Low
$2.03

Select another date:

Wed, May 9 2018

BRIEF-Cellectar Granted Orphan Drug Designation For CLR 131

* CELLECTAR GRANTED ORPHAN DRUG DESIGNATION FOR CLR 131 TO TREAT RHABDOMYOSARCOMA Source text for Eikon: Further company coverage:

Select another date: